Related Experiment Videos
[Therapy of immune thrombopenia]
1Medizinische Poliklinik, Universitätsspital Zürich.
Schweizerische Medizinische Wochenschrift
|June 8, 1991
Summary
Immune thrombocytopenia (ITP) is an autoimmune disorder. This review covers ITP treatments, including standard therapies and alternative options when initial treatments fail.
Area of Science:
- Immunology
- Hematology
- Autoimmune Diseases
Context:
- Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by low platelet counts.
- The term 'idiopathic' is outdated; ITP is now understood as immune-mediated thrombocytopenia.
- ITP presents in acute and chronic forms, requiring distinct management strategies.
Purpose:
- To review current and alternative treatment modalities for immune thrombocytopenia.
- To discuss the efficacy and mechanisms of various ITP therapies.
- To provide an overview of treatment options based on clinical study data.
Summary:
- This review examines immune thrombocytopenia (ITP), an autoimmune condition.
- It details treatment approaches for both acute and chronic ITP.
- The discussion includes standard treatments like prednisone and gammaglobulins, splenectomy, and alternative experimental therapies when initial interventions are unsuccessful.
Impact:
- Informs clinicians about the evolving understanding and treatment landscape of ITP.
- Highlights the need for alternative therapies when standard treatments fail.
- Contributes to improved patient management strategies for immune thrombocytopenia.